
List of Topics
| 1. Innate Immunity |
| 1.01 Lectins and glycoimmunology |
| 1.02 Toll-like receptors 1 |
| 1.03 Toll-like receptors 2 |
| 1.04 Intracellular receptors for viral and bacterial infections |
| 1.05 Fc and Fc-like receptors |
| 1.06 Complement system |
| 1.07 Signalling in pattern recognition |
| 1.08 Inflammasome |
| 1.09 Lipid mediators in immune reaction |
| 1.10 Inflammatory cytokines and anti-microbial responses |
| 1.11 Macrophages |
| 1.12 Neutrophils and other myeloid cells |
| 1.13 Dendritic cells: differentiation |
| 1.14 Dendritic cells: function 1 |
| 1.15 Dendritic cells: function 2 |
| 1.16 NK cells and NK receptors |
| 1.17 CD1d/NKT Cells |
| 1.18 Gamma-delta T cells |
| 1.19 Autophagy and membrane trafficking in immune reaction |
| 1.20 Gut flora and inflammation |
| 1.21 NO and ROS in immune responses |
| 1.22 Evolution of immune system and invertebrate immunity |
| 2. Adaptive Immunity |
| 2.01 Hematopoietic stem cells (+iPS) |
| 2.02 Hematopoiesis/early commitment |
| 2.03 Lymphoid organogenesis |
| 2.04 Thymic selection |
| 2.05 Lineage commitment |
| 2.06 T cell development |
| 2.07 B cell development |
| 2.08 Genetic rearrangements (VDJ/CSR/SHM) |
| 2.09 Th1/Th2 |
| 2.10 Th17 |
| 2.11 Regulatory T cells 1 |
| 2.12 Regulatory T cells 2 |
| 2.13 CTL differentiation and function |
| 2.14 T cell homeostasis and memory |
| 2.15 B cell memory |
| 2.16 Germinal center reaction |
| 2.17 Plasma cell differentiation |
| 2.18 Antigen receptor signaling |
| 2.19 Cytokine receptors and signaling |
| 2.20 Costimulation |
| 2.21 Antigen processing and presentation |
| 2.22 Cell death in immune system |
| 2.23 Chemotaxis in immunity |
| 2.24 Cell adhesion in immunity |
| 2.25 Leucocyte trafficking |
| 2.26 Imaging of immune system |
| 2.27 Mucosal immunity: homeostasis |
| 2.28 Mucosal immunity: immune response |
| 2.29 Tumor immunity and immunosurveillance 1 |
| 2.30 Tumor immunity and immunosurveillance 2 |
| 2.31 Peripheral tolerance and lymphocyte anergy |
| 3. Infection |
| 3.01 Immunity to virus infection (excluding retroviruses) 1 |
| 3.02 Immunity to virus infection (excluding retroviruses) 2 |
| 3.03 Immunity to retrovirus infection |
| 3.04 Immunity to bacterial infection (excluding mycobacteria) |
| 3.05 Immunity to mycobacterial infection |
| 3.06 Immunity to protozoan parasite infection |
| 3.07 Immunity to helminth infection |
| 3.08 Immunity to fungal infection |
| 3.09 Immunity to emerging infectious diseases |
| 3.10 HIV pathogenesis and immunity |
| 4. Allergy |
| 4.01 Environmental factors in allergies |
| 4.02 IgE-mediated allergic responses |
| 4.03 Basophils, eosinophils in allergic responses |
| 4.04 Mast cell in allergic responses |
| 4.05 Asthma |
| 4.06 Atopic dermatitis and allergic rhinitis |
| 4.07 Prevention and intervention of allergy |
| 4.08 Genetic factors and epidemiology of allergic diseases |
| 4.09 Allergic mediators |
| 5. Diseases |
| 5.01 Genetics of autoimmunity |
| 5.02 Environmental factors of autoimmunity |
| 5.03 MHC polymorphism and diseases |
| 5.04 Primary immunodeficiency |
| 5.05 Inflammatory and fibrotic lung diseases |
| 5.06 Vasculitis and inflammatory cardiovascular |
| 5.07 Diabetes |
| 5.08 Immunoendocrinology and metabolism |
| 5.09 Rheumatoid arthritis and other inflammatory joint diseases (animal models) |
| 5.10 Rheumatoid arthritis and other inflammatory joint diseases (human studies) |
| 5.11 SLE and other connective tissue diseases (animal models) |
| 5.12 SLE and other connective tissue diseases (human studies) |
| 5.13 Immunology of chronic liver diseases |
| 5.14 Inflammatory bowel diseases |
| 5.15 Neuroimmunology |
| 5.16 Multiple sclerosis |
| 5.17 Reproductive immunology |
| 5.18 Immunological kidney diseases |
| 5.19 Psoriasis and skin diseases |
| 5.20 Immunological diseases of the eye |
| 5.21 Osteoimmunology |
| 5.22 Atherosclerosis |
| 5.23 Regulatory T cells and autoimmunity |
| 5.24 Cytokine regulation in diseases |
| 5.25 Myelo- and lympho-proliferative disorders |
| 6. Translational |
| 6.01 Vaccination and immunotherapy of viral diseases |
| 6.02 Vaccination and immunotherapy against bacteria, fungi and parasites |
| 6.03 Tumor vaccines |
| 6.04 Antibody therapy |
| 6.05 Bone marrow transplantation and graft versus host disease |
| 6.06 Organ transplantation |
| 6.07 DC-based anti-tumor immunotherapy |
| 6.08 CTL-based immunotherapy |
| 6.09 Cell therapy (DC, Treg, NKT) |
| 6.10 Mucosal vaccines |
| 6.11 Veterinary immunology |
| 6.12 Humanized mouse |
| 7. Others |
| 7.01 Structural biology in immunology |
| 7.02 Epigenetic control of immune responses |
| 7.03 Aging and immunity |
| 7.04 MicroRNAs in immune development/responses |
| 7.05 New technology in immunology |
| 7.06 Systems immunology |